Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034268PMC
http://dx.doi.org/10.4103/1673-5374.270420DOI Listing

Publication Analysis

Top Keywords

pazopanib-induced posterior
4
posterior reversible
4
reversible encephalopathy
4
encephalopathy syndrome
4
syndrome syndrome
4
syndrome inappropriate
4
inappropriate secretion
4
secretion antidiuretic
4
antidiuretic hormone
4
hormone incidental
4

Similar Publications

Posterior reversible encephalopathy syndrome (PRES) is a reversible clinical and neuroradiological syndrome which may appear at any age and characterized by headache, altered consciousness, seizures, and cortical blindness. The exact incidence is still unknown. The most commonly identified causes include hypertensive encephalopathy, eclampsia, and some cytotoxic drugs.

View Article and Find Full Text PDF

Background: The reversible posterior leukoencephalopathy syndrome is a clinical/radiological syndrome characterized by headache, seizures, impaired vision, acute hypertension, and typical magnetic resonance imaging findings. There are several reports in the literature that depict its occurrence in cancer patients. The list of common anticancer and supportive care drugs that predispose to reversible posterior leukoencephalopathy syndrome is expanding and includes not only a large number of chemotherapeutic agents but also an increased number of new targeted drugs, particularly angiogenesis inhibitors such as bevacizumab,sorefenib and sunitinib.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!